seventy-eight individuals previously treated with chemotherapy for non-hodgkin 's lymphoma were enrolled in a phase ii pilot study employing methotrexate 100 mg/m2 iv ( day 1 ) , calcium leucovorin 10 mg/m2 iv and/or po q6h ( days 2-4 ) , vm-26 ( teniposide ) 100 mg/m2 iv ( days 2 and 9 ) , procarbazine 100 mg/m2 po ( days 2-15 ) , and dexamethasone 15 mg/m2po ( days 2-8 ) ( mv26pd ) .
C0024305
non-hodgkin 's
C0033223
procarbazine